Liu Yanyan, Cheng Yue, Yang Haifei, Hu Lifen, Cheng Jun, Ye Ying, Li Jiabin
Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China.
Anhui Center for Surveillance of Bacterial Resistance, Hefei, Anhui 230022, China.
Ann Lab Med. 2017 Sep;37(5):415-419. doi: 10.3343/alm.2017.37.5.415.
The emergence of fosfomycin resistance and extended-spectrum β-lactamase (ESBL) genes is a serious threat to public health and a new challenge in shigellosis treatment. The purpose of this study was to identify fosfomycin resistance and characterize β-lactamase genes in fos-carrying isolates of Shigella flexneri from patients in China.
A total of 263 S. flexneri isolates were collected from 34 hospitals in the Anhui Province of China during September 2012-September 2015 and screened for fosA3, fosA, and fosC2 by PCR amplification and sequencing. The fos-carrying isolates were then screened for β-lactamase genes. The clonal relationships between fosA3-carrying isolates, the transmissibility of fosfomycin resistance, replicon types of plasmids carrying fosfomycin resistance genes and other associated resistance genes were investigated.
Twenty-five of the 263 isolates (9.5%) showed resistance to fosfomycin, and 18 (6.8%) were positive for fosA3. None of the isolates was positive for fosA or fosC2. Seventeen of the isolates carrying fosA3 (94%) were CTX-M producers (seven CTX-M-55, five CTX-M-14, and five CTX-M-123), while three (16.7%) were TEM producers (TEM-1).Sixteen (88.9%) fosA3-carrying isolates exhibited multi-drug resistance. The replicon types of the 13 fosA3-carrying plasmids were IncF (n=13), IncHI2 (n=3), IncIl-Ir (n=2), and IncN (n=1).
Our results indicated that fosA3 could spread through plasmids in S. flexneri isolates, along with the bla(CTX-M) and bla(TEM), which facilitate its quick dispersal. To the best of our knowledge, this is the first report of CTX-M-123-type ESBLs in S. flexneri isolates from patients in China.
磷霉素耐药性及超广谱β-内酰胺酶(ESBL)基因的出现对公共卫生构成严重威胁,也是志贺菌病治疗面临的新挑战。本研究旨在鉴定中国患者中福氏志贺菌携带磷霉素的分离株的磷霉素耐药性并对β-内酰胺酶基因进行特征分析。
2012年9月至2015年9月期间,从中国安徽省34家医院收集了263株福氏志贺菌分离株,通过PCR扩增和测序筛选福氏志贺菌A3(fosA3)、福氏志贺菌A(fosA)和福氏志贺菌C2(fosC2)。然后对携带磷霉素的分离株进行β-内酰胺酶基因筛选。研究了携带fosA3的分离株之间的克隆关系、磷霉素耐药性的传播性、携带磷霉素耐药基因的质粒的复制子类型以及其他相关耐药基因。
263株分离株中有25株(9.5%)对磷霉素耐药,18株(6.8%)fosA3呈阳性。分离株中fosA或fosC2均无阳性。17株携带fosA3的分离株(94%)产CTX-M(7株CTX-M-55、5株CTX-M-14和5株CTX-M-123),而3株(16.7%)产TEM(TEM-1)。16株(88.9%)携带fosA3的分离株表现出多重耐药性。13株携带fosA3的质粒的复制子类型为IncF(n=13)、IncHI2(n=3)、IncIl-Ir(n=2)和IncN(n=1)。
我们的结果表明,fosA3可通过质粒在福氏志贺菌分离株中传播,同时携带bla(CTX-M)和bla(TEM),这有助于其快速扩散。据我们所知,这是中国患者福氏志贺菌分离株中CTX-M-123型ESBLs的首次报道。